Current Status of Renal Replacement Therapy in Turkey: A Summary of the Turkish Society of Nephrology Registry Report

Objective: Every year, the registry of the Turkish Society of Nephrology conducts data collection on hemodialysis, peritoneal dialysis, and transplantation. Registry reports are printed annually as a booklet, thus making 2019 the 29th year of registry reports. The registry is in close collaboration with international registries. Materials and Methods: This paper summarizes the data from the 2018 registry report. Additionally, this paper provides the yearly trends in the management of end-stage renal disease. Results: There is an alarming increase in the number of patients undergoing renal replacement therapy (RRT). At the end of 2018, 81,055 patients had undergone RRT. The prevalence and incidence of end-stage renal disease were 988 and 149 per million populations, respectively. Diabetes was termed as the most widespread cause of end-stage renal disease. Hemodialysis (74.8%) serves as the most common type of treatment modality, followed by transplantation (21.2%) and peritoneal dialysis (3.9%). Conclusion: End-stage renal disease is a critical and growing health concern in our country. The Turkish Renal Registry of the Turkish Society of Nephrology continues to be one of the leading tools for providing the current and sound data on this public health problem. Cite this article as: Seyahi N, Ateş K, Süleymanlar G. Current Status of Renal Replacement Therapy in Turkey: A Summary of the Turkish Society of Nephrology Registry Report. Turk J Nephrol 2020; 29(1): 6-11.